Delivered double-digit Adjusted EPS growth
in 2024; Well-positioned for strong operational performance in
2025
Fourth Quarter 2024 Highlights
(All comparisons against the fourth quarter of 2023 unless
otherwise noted)
Strong performance driven by its competitive differentiator -
Ingersoll Rand Execution Excellence (IRX):
- Reported orders of $1,800 million, up 8%
- Reported revenues of $1,899 million, up 4%
- Reported net income attributable to Ingersoll Rand Inc. of $230
million, or earnings of $0.57 per share
- Adjusted net income1 of $344 million, or $0.84 per share
- Adjusted EBITDA1 of $532 million, up 6%, with a margin of
28.0%, up 50 basis points year-over-year, and incremental margin of
41%
- Reported operating cash flow of $526 million and free cash
flow1 of $491 million
- Free cash flow margin1 of 26%
- Liquidity of $4.1 billion as of December 31, 2024, including
$1.5 billion of cash on hand and undrawn capacity of $2.6 billion
under available credit facilities
Full-Year 2024 Highlights
(All comparisons against 2023 unless otherwise noted)
- Reported orders of $7,106 million, up 4%
- Reported revenues of $7,235 million, up 5%
- Reported net income attributable to Ingersoll Rand Inc. of $839
million, or earnings of $2.06 per share
- Adjusted net income1 of $1,349 million, or $3.29 per share, up
11%
- Adjusted EBITDA1 of $2,018 million, up 13%, with a margin of
27.9%, up 190 basis points year-over-year, and incremental margin
of 64%
- Reported operating cash flow of $1,397 million and free cash
flow1 of $1,248 million
- Free cash flow margin1 of 17%
- Returned $293 million of value to shareholders through share
repurchases and dividends
2025 Guidance
- Expect full-year 2025 revenue growth of 3% to 5% and Adjusted
EBITDA1 of $2,130 to $2,190 million, up 6% to 9% over prior
year
- 2025 Adjusted EPS1 expected to be in a range of $3.38 to $3.50,
up 3% to 6% over prior year
Ingersoll Rand Inc. (NYSE: IR), a global provider of
mission-critical flow creation and life sciences and industrial
solutions, reported record results for both the fourth quarter and
the full-year 2024.
“I am proud of our global team’s strong execution and
performance, driven by IRX, as we delivered double-digit earnings
growth and strong free cash flow margin in 2024,” said Vicente
Reynal, chairman and chief executive officer of Ingersoll Rand. “We
also significantly outpaced our inorganic growth commitments last
year and are poised for another strong year of M&A activity in
2025. In what continues to be a dynamic global market environment,
we remain nimble and focused as we continue to deliver financial
durability by meeting our long-term commitments.”
__________________________________________
1 Non-GAAP measure (definitions and/or
reconciliations in tables below).
Fourth Quarter 2024 Segment Review
(All comparisons against the fourth quarter of 2023 unless
otherwise noted.)
Industrial Technologies and Services Segment (IT&S):
Broad range of compressor, vacuum, blower, and air treatment
solutions as well as industrial technologies including power tools
and lifting equipment
- Reported Orders of $1,422 million, up 3%, or flat
organic
- Reported Revenues of $1,511 million, flat, or down 2%
organic2
- Reported Segment Adjusted EBITDA of $458 million, up
1%
- Reported Segment Adjusted EBITDA Margin of 30.3%, up 30
basis points
- The fourth quarter saw solid Adjusted EBITDA margin improvement
year-over-year on top of record-level margin in the fourth quarter
of the prior year. In addition, for the full-year Adjusted EBITDA
margin finished at a record level of 30.2%. For the fourth quarter,
orders grew low-single-digits organically excluding the impact of
the Power Tools and Lifting business and China.
Precision and Science Technologies Segment (P&ST):
Mission-critical precision liquid, gas, air, and powder handling
technologies for life sciences and industrial applications as well
as aerospace and defense applications
- Reported Orders of $378 million, up 29%, or down 1%
organic
- Reported Revenues of $388 million, up 24%, or down 5%
organic2
- Reported Segment Adjusted EBITDA of $107 million, up
14%
- Reported Segment Adjusted EBITDA Margin of 27.6%, down
250 basis points
- Orders and revenue both finished relatively flat sequentially.
Excluding the impact of China, the segment saw organic order growth
year over year in the low-single-digits. The decline in the fourth
quarter Adjusted EBITDA margin was largely driven by lower volumes
in the ILC Dover Aerospace and Defense business and organic volume
declines primarily driven by China.
Balance Sheet and Cash Flow
Ingersoll Rand remains in a strong financial position with ample
liquidity of $4.1 billion. On a reported basis, the Company
generated $526 million of cash flow from operating activities and
invested $35 million in capital expenditures, resulting in free
cash flow2 of $491 million, compared to cash flow from operating
activities of $581 million and free cash flow2 of $552 million in
the prior year period. Net debt to Adjusted EBITDA2 leverage was
1.6x for the fourth quarter, which was an increase of 1.0x as
compared to the prior year driven by the acquisition of ILC Dover,
which took place in the second quarter of 2024.
Consistent with our comprehensive capital allocation strategy
led by M&A, in the fourth quarter Ingersoll Rand deployed $200
million to M&A. The Company also returned $71 million to
shareholders through $63 million in share repurchases and $8
million through its quarterly dividend payment in the fourth
quarter.
Since December 2024, Ingersoll Rand also closed on the following
acquisitions:
- SSI Aeration, a leading global manufacturer in the design and
manufacturing of wastewater treatment plant equipment.
- Excelsior Blower Systems, a key provider and packager of blower
technology.
- Toshniwal Industries Pvt. Ltd., a leading manufacturer of
vacuum pumps and vacuum systems.
2025 Guidance2,3,4,5
Ingersoll Rand is establishing its full-year 2025 guidance.
Key Metrics
Revenue - Total Ingersoll Rand3
3-5%
Ingersoll Rand (Organic)2
1-3%
Industrial Technologies & Services
(Organic)
1-3%
Precision & Science Technologies
(Organic)
1-3%
FX Impact4
(~2%)
M&A5
~$300M / ~4%
Corporate Costs
(~$165M)
Adjusted EBITDA2
$2,130M - $2,190M (+6% -
+9%)
Adjusted EPS2
$3.38 - $3.50 (+3% -
+6%)
Full-year 2025 phasing assumptions:
- Total revenue growth of 3-5% expected in both the first and
second half of the year.
- Phasing of revenue and Adjusted EBITDA consistent with prior
years.
- FX, based on December 2024 year-end rates, is expected to
impact revenue in both the first and second half of the year
consistently.
- Revenue from completed M&A is expected to be realized
primarily in the first half of the year.
- Corporate costs are expected to be incurred relatively evenly
throughout the year.
- Adjusted EPS phasing is consistent with the Adjusted EBITDA
phasing.
__________________________________________
2 Non-GAAP measure (definitions and/or
reconciliations in tables below).
3 All revenue outlook commentary expressed
in percentages and based on growth as compared to 2024.
4 Based on December 2024 FX rates; does
not include the impact of FX on M&A.
5 Reflects all completed and closed
M&A as of February 12, 2025.
Reconciliations of non-GAAP measures related to full-year 2025
guidance have not been provided due to the unreasonable efforts it
would take to provide such reconciliations due to the high
variability, complexity and uncertainty with respect to forecasting
and quantifying certain amounts that are necessary for such
reconciliations, including net income (loss) and adjustments that
could be made for acquisitions-related expenses, restructuring and
other business transformation costs, gains or losses on foreign
currency exchange and the timing and magnitude of other amounts in
the reconciliation of historic numbers. For the same reasons, we
are unable to address the probable significance of the unavailable
information, which could have a potentially unpredictable, and
potentially significant, impact on our future GAAP financial
results.
Conference Call
Ingersoll Rand will host a live earnings conference call to
discuss the fourth quarter and full year results on Friday,
February 14, 2025 at 8:00 a.m. (Eastern Time). To participate in
the call, please dial 1-888-330-3073, domestically, or
1-646-960-0683, internationally, and use access code 8970061. A
real-time audio webcast of the presentation can be accessed via the
Events and Presentations section of the Ingersoll Rand Investor
Relations website (https://investors.irco.com), where related
materials will be posted prior to the conference call. A replay of
the webcast will be available after conclusion of the conference
and can be accessed on the Ingersoll Rand Investor Relations
website.
Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements related to expectations of Ingersoll
Rand Inc. (the “Company” or “Ingersoll Rand”) regarding the
performance of its business, its financial results, its liquidity
and capital resources and other non-historical statements. These
forward-looking statements generally are identified by the words
“believe,” “project,” “expect,” “anticipate,” “estimate,”
“forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,”
“intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,”
“would,” “will be,” “on track to” “will continue,” “will likely
result,” “guidance” or the negative thereof or variations thereon
or similar terminology generally intended to identify
forward-looking statements. All statements other than historical
facts are forward-looking statements.
These forward-looking statements are based on Ingersoll Rand’s
current expectations and are subject to risks and uncertainties,
which may cause actual results to differ materially from these
current expectations. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated
or anticipated by such forward-looking statements. The inclusion of
such statements should not be regarded as a representation that
such plans, estimates or expectations will be achieved. Important
factors that could cause actual results to differ materially from
such plans, estimates or expectations include, among others, (1)
adverse impact on our operations and financial performance due to
geopolitical tensions, natural disaster, catastrophe, global
pandemics, cyber events, or other events outside of our control;
(2) unexpected costs, charges or expenses resulting from completed
and proposed business combinations; (3) uncertainty of the expected
financial performance of the Company; (4) failure to realize the
anticipated benefits of completed and proposed business
combinations; (5) the ability of the Company to implement its
business strategy; (6) difficulties and delays in achieving revenue
and cost synergies; (7) inability of the Company to retain and hire
key personnel; (8) evolving legal, regulatory and tax regimes; (9)
changes in general economic and/or industry specific conditions;
(10) actions by third parties, including government agencies; and
(11) other risk factors detailed in Ingersoll Rand’s most recent
Annual Report on Form 10-K filed with the Securities and Exchange
Commission (the “SEC”), as such factors may be updated from time to
time in its periodic filings with the SEC, which are available on
the SEC’s website at http://www.sec.gov. The foregoing list of
important factors is not exclusive.
Any forward-looking statements speak only as of the date of this
release. Ingersoll Rand undertakes no obligation to update any
forward-looking statements, whether as a result of new information
or developments, future events or otherwise, except as required by
law. Readers are cautioned not to place undue reliance on any of
these forward-looking statements.
About Ingersoll Rand Inc.
Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial
spirit and ownership mindset, is dedicated to Making Life Better
for our employees, customers, shareholders, and planet. Customers
lean on us for exceptional performance and durability in
mission-critical flow creation and life sciences and industrial
solutions. Supported by over 80+ respected brands, our products and
services excel in the most complex and harsh conditions. Our
employees develop customers for life through their daily commitment
to expertise, productivity, and efficiency. For more information,
visit www.IRCO.com.
Non-U.S. GAAP Measures of Financial Performance
In addition to consolidated GAAP financial measures, Ingersoll
Rand reviews various non-GAAP financial measures, including
“Organic Revenue Growth/(Decline),” “Adjusted EBITDA,” “Adjusted
EBITDA Margin,” “Adjusted Net Income,” “Adjusted Diluted EPS,”
“Free Cash Flow,” and “Free Cash Flow Margin.”
Ingersoll Rand believes Adjusted EBITDA, Adjusted EBITDA Margin,
Adjusted Net Income, and Adjusted Diluted EPS are helpful
supplemental measures to assist management and investors in
evaluating the Company’s operating results as they exclude certain
items that are unusual in nature or whose fluctuation from period
to period do not necessarily correspond to changes in the
operations of Ingersoll Rand’s business. Ingersoll Rand believes
Organic Revenue Growth/(Decline) is a helpful supplemental measure
to assist management and investors in evaluating the Company’s
operating results as it excludes the impact of foreign currency and
acquisitions on revenue growth. Adjusted EBITDA represents net
income before interest, taxes, depreciation, amortization and
certain non-cash, non-recurring and other adjustment items.
Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by
Revenue. Adjusted Net Income is defined as net income including
interest, depreciation and amortization of non-acquisition related
intangible assets and excluding other items used to calculate
Adjusted EBITDA and further adjusted for the tax effect of these
exclusions. Adjusted Diluted EPS is defined as Adjusted Net Income
divided by Adjusted Diluted Average Shares Outstanding. Organic
Revenue Growth/(Decline) is defined as As Reported Revenue growth
less the impacts of Foreign Currency and Acquisitions. Ingersoll
Rand believes that the adjustments applied in presenting Adjusted
EBITDA and Adjusted Net Income are appropriate to provide
additional information to investors about certain material non-cash
items and about non-recurring items that the Company does not
expect to continue at the same level in the future.
Incrementals/Decrementals are defined as the change in Adjusted
EBITDA versus the prior year period divided by the change in
revenue versus the prior year period.
Ingersoll Rand uses Free Cash Flow and Free Cash Flow Margin to
review the liquidity of its operations. Ingersoll Rand measures
Free Cash Flow as cash flows from operating activities less capital
expenditures. Free Cash Flow Margin is defined as Free Cash Flow
divided by Revenue. Ingersoll Rand believes Free Cash Flow and Free
Cash Flow Margin are useful supplemental financial measures for
management and investors in assessing the Company’s ability to
pursue business opportunities and investments and to service its
debt. Free Cash Flow is not a measure of our liquidity under GAAP
and should not be considered as an alternative to cash flows from
operating activities.
Management and Ingersoll Rand’s board of directors regularly use
these measures as tools in evaluating the Company’s operating and
financial performance and in establishing discretionary annual
compensation. Such measures are provided in addition to, and should
not be considered to be a substitute for, or superior to, the
comparable measures under GAAP. In addition, Ingersoll Rand
believes that Organic Revenue Growth/(Decline), Adjusted EBITDA,
Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS,
Incrementals/Decrementals, Free Cash Flow and Free Cash Flow Margin
are frequently used by investors and other interested parties in
the evaluation of issuers, many of which also present Adjusted
EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted
Diluted EPS, Free Cash Flow and Free Cash Flow Margin when
reporting their results in an effort to facilitate an understanding
of their operating and financial results and liquidity.
Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted
EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash
Flow and Free Cash Flow Margin should not be considered as
alternatives to revenue growth, net income, diluted earnings per
share or any other performance measure derived in accordance with
GAAP, or as alternatives to cash flow from operating activities as
a measure of our liquidity. Organic Revenue Growth/(Decline),
Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income,
Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin have
limitations as analytical tools, and you should not consider such
measures either in isolation or as substitutes for analyzing
Ingersoll Rand’s results as reported under GAAP.
Reconciliations of Organic Revenue Growth/(Decline), Adjusted
EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted
Diluted EPS, Free Cash Flow and Free Cash Flow Margin to their most
comparable U.S. GAAP financial metrics for historical periods are
presented in the tables below.
Reconciliations of non-GAAP measures related to full year 2025
guidance have not been provided due to the unreasonable efforts it
would take to provide such reconciliations due to the high
variability, complexity and uncertainty with respect to forecasting
and quantifying certain amounts that are necessary for such
reconciliations, including net income (loss) and adjustments that
could be made for acquisitions-related expenses, restructuring and
other business transformation costs, gains or losses on foreign
currency exchange and the timing and magnitude of other amounts in
the reconciliation of historic numbers. For the same reasons, we
are unable to address the probable significance of the unavailable
information, which could have a potentially unpredictable, and
potentially significant, impact on our future GAAP financial
results.
INGERSOLL RAND INC. AND
SUBSIDIARIES
CONSOLIDATED STATEMENTS OF
OPERATIONS
(Unaudited; in millions, except
per share amounts)
For the Three Month Period
Ended December 31,
For the Twelve Month Period
Ended December 31,
2024
2023
2024
2023
Revenues
$
1,898.6
$
1,821.4
$
7,235.0
$
6,876.1
Cost of sales
1,083.2
1,040.2
4,065.0
3,993.9
Gross Profit
815.4
781.2
3,170.0
2,882.2
Selling and administrative expenses
331.7
330.8
1,344.4
1,272.7
Amortization of intangible assets
95.2
93.2
373.0
367.5
Impairment of other intangible assets
13.9
—
13.9
—
Other operating expense, net
(4.2
)
24.0
138.6
77.7
Operating Income
378.8
333.2
1,300.1
1,164.3
Interest expense
61.8
37.4
213.2
156.7
Loss on extinguishment of debt
—
—
3.0
13.5
Other income, net
(8.1
)
(11.6
)
(48.9
)
(37.0
)
Income Before Income Taxes
325.1
307.4
1,132.8
1,031.1
Provision for income taxes
88.2
71.1
262.5
240.0
Loss on equity method investments
(5.0
)
(4.8
)
(24.0
)
(6.0
)
Net Income
231.9
231.5
846.3
785.1
Less: Net income attributable to
noncontrolling interests
2.1
1.7
7.7
6.4
Net Income Attributable to Ingersoll
Rand Inc.
$
229.8
$
229.8
$
838.6
$
778.7
Basic earnings per share
0.57
0.57
2.08
1.92
Diluted earnings per share
0.57
0.56
2.06
1.90
INGERSOLL RAND INC. AND
SUBSIDIARIES
CONSOLIDATED BALANCE
SHEETS
(Unaudited; in millions, except
share amounts)
December 31, 2024
December 31, 2023
Assets
Current assets:
Cash and cash equivalents
$
1,541.2
$
1,595.5
Accounts receivable, net of allowance for
credit losses of $57.3 and $53.8, respectively
1,335.4
1,234.2
Inventories
1,055.0
1,001.1
Other current assets
231.9
219.6
Total current assets
4,163.5
4,050.4
Property, plant and equipment, net of
accumulated depreciation of $567.5 and $500.8, respectively
842.1
711.4
Goodwill
8,148.1
6,609.7
Other intangible assets, net
4,372.8
3,611.1
Deferred tax assets
26.1
31.5
Other assets
457.2
549.4
Total assets
$
18,009.8
$
15,563.5
Liabilities and Stockholders’
Equity
Current liabilities:
Short-term borrowings and current
maturities of long-term debt
$
3.1
$
30.6
Accounts payable
843.6
801.2
Accrued liabilities
972.2
995.5
Total current liabilities
1,818.9
1,827.3
Long-term debt, less current
maturities
4,754.4
2,693.0
Pensions and other postretirement
benefits
139.3
150.0
Deferred income tax liabilities
757.6
612.6
Other liabilities
294.3
433.9
Total liabilities
$
7,764.5
$
5,716.8
Stockholders’ equity:
Common stock, $0.01 par value;
1,000,000,000 shares authorized; 430,745,964 and 428,589,061 shares
issued as of December 31, 2024 and 2023, respectively
4.3
4.3
Capital in excess of par value
9,633.6
9,550.8
Retained earnings
2,503.5
1,697.2
Accumulated other comprehensive loss
(468.5
)
(227.6
)
Treasury stock at cost; 27,865,885 and
25,241,667 shares as of December 31, 2024 and 2023,
respectively
(1,493.9
)
(1,240.9
)
Total Ingersoll Rand stockholders’
equity
$
10,179.0
$
9,783.8
Noncontrolling interests
66.3
62.9
Total stockholders’ equity
$
10,245.3
$
9,846.7
Total liabilities and stockholders’
equity
$
18,009.8
$
15,563.5
INGERSOLL RAND INC. AND
SUBSIDIARIES
CONSOLIDATED STATEMENTS OF
CASH FLOWS
(Unaudited; in millions)
Twelve Month Period Ended
December 31,
2024
2023
Cash Flows From Operating
Activities:
Net income
$
846.3
$
785.1
Adjustments to reconcile net income to net
cash provided by operating activities:
Amortization of intangible assets
373.0
367.5
Depreciation
109.0
91.6
Impairment of intangible assets
13.9
—
Non-cash restructuring charges
1.6
2.7
Stock-based compensation expense
58.8
51.9
Loss (income) on equity method
investments
24.0
6.0
Foreign currency transaction losses,
net
3.2
5.1
Non-cash adjustments to carrying value of
LIFO inventories
6.7
12.0
Loss on extinguishment of debt
3.0
13.5
Loss on sale of asbestos-related assets
and liabilities
33.7
—
Deferred income taxes
(33.1
)
(76.9
)
Other non-cash adjustments
7.7
8.3
Changes in assets and liabilities:
Receivables
(45.1
)
(48.6
)
Inventories
39.8
117.3
Accounts payable
13.3
(23.9
)
Accrued liabilities
(34.5
)
94.8
Other assets and liabilities, net
(24.6
)
(29.0
)
Net cash provided by operating
activities
1,396.7
1,377.4
Cash Flows From Investing
Activities:
Capital expenditures
(149.1
)
(105.4
)
Net cash paid in acquisitions
(2,958.7
)
(963.0
)
Disposals of property, plant and
equipment
6.1
7.6
Other investing
(6.0
)
0.3
Net cash used in investing activities
(3,107.7
)
(1,060.5
)
Cash Flows From Financing
Activities:
Principal payments on long-term debt
(1,242.7
)
(1,518.0
)
Proceeds from long-term debt
3,296.9
1,490.4
Purchases of treasury stock
(260.7
)
(263.0
)
Cash dividends on common stock
(32.3
)
(32.4
)
Proceeds from stock option exercises
32.2
30.3
Payments to settle cross-currency
swaps
(19.9
)
—
Payments of deferred and contingent
acquisition consideration
(23.4
)
(17.5
)
Payments of debt issuance costs
(32.3
)
(18.5
)
Other financing
(10.3
)
(8.8
)
Net cash provided by (used in) financing
activities
1,707.5
(337.5
)
Effect of exchange rate changes on cash
and cash equivalents
(50.8
)
3.1
Net decrease in cash and cash
equivalents
(54.3
)
(17.5
)
Cash and cash equivalents, beginning of
year
1,595.5
1,613.0
Cash and cash equivalents, end of year
$
1,541.2
$
1,595.5
INGERSOLL RAND INC. AND
SUBSIDIARIES
UNAUDITED ADJUSTED FINANCIAL
INFORMATION
(Dollars in millions)
For the Three Months Ended
December 31,
For the Twelve Months Ended
December 31,
2024
2023
2024
2023
Revenues
$
1,898.6
$
1,821.4
$
7,235.0
$
6,876.1
Adjusted EBITDA
$
532.3
$
500.5
$
2,018.1
$
1,786.8
Adjusted EBITDA Margin
28.0
%
27.5
%
27.9
%
26.0
%
Free Cash Flow
$
490.9
$
551.8
$
1,247.6
$
1,272.0
Free Cash Flow Margin
25.9
%
30.3
%
17.2
%
18.5
%
INGERSOLL RAND INC. AND
SUBSIDIARIES
RECONCILIATION OF NET INCOME
TO ADJUSTED NET INCOME ATTRIBUTABLE TO
INGERSOLL RAND INC. and
ADJUSTED DILUTED EARNINGS PER SHARE
(Unaudited; in millions)
For the Three Months Ended
December 31,
For the Twelve Months Ended
December 31,
2024
2023
2024
2023
Net Income
$
231.9
$
231.5
$
846.3
$
785.1
Plus:
Provision for income taxes
88.2
71.1
262.5
240.0
Amortization of acquisition related
intangible assets
93.0
90.8
364.3
357.5
Impairment of intangible assets
13.9
—
13.9
—
Restructuring and related business
transformation costs
8.0
10.5
32.3
22.9
Acquisition and other transaction related
expenses and non-cash charges
0.3
17.3
59.8
63.9
Stock-based compensation
15.2
16.7
58.8
51.9
Foreign currency transaction losses
(gains), net
(6.0
)
4.1
3.2
5.1
Loss on equity method investments
5.0
4.8
24.0
6.0
Loss on extinguishment of debt
—
—
3.0
13.5
Adjustments to LIFO inventories
(0.5
)
(2.0
)
6.7
12.0
Cybersecurity incident costs
—
—
0.5
2.3
Loss on asbestos sale
—
—
58.8
—
Other adjustments
(0.6
)
2.5
0.4
0.8
Minus:
Income tax provision, as adjusted
104.8
92.7
385.2
345.2
Adjusted Net Income
343.6
354.6
1,349.3
1,215.8
Less: Net income attributable to
noncontrolling interest
2.1
1.7
7.7
6.4
Adjusted Net Income Attributable to
Ingersoll Rand Inc.
$
341.5
$
352.9
$
1,341.6
$
1,209.4
Adjusted Basic Earnings Per
Share1
$
0.85
$
0.87
$
3.33
$
2.99
Adjusted Diluted Earnings Per
Share2
$
0.84
$
0.86
$
3.29
$
2.96
Average shares outstanding:
Basic, as reported
403.0
404.2
403.4
404.8
Diluted, as reported
406.6
408.2
407.2
409.0
Adjusted diluted2
406.6
408.2
407.2
409.0
1 Basic and diluted earnings per share (as
reported) are calculated by dividing net income attributable to
Ingersoll Rand Inc. by the basic and diluted average shares
outstanding for the respective periods.
2 Adjusted diluted share count and
adjusted diluted earnings per share include incremental dilutive
shares, using the treasury stock method, which are added to average
shares outstanding.
INGERSOLL RAND INC. AND
SUBSIDIARIES
RECONCILIATION OF NET INCOME
TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS FROM
OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited; in millions)
For the Three Month Period
Ended December 31,
For the Twelve Month Period
Ended December 31,
2024
2023
2024
2023
Net Income
$
231.9
$
231.5
$
846.3
$
785.1
Plus:
Interest expense
61.8
37.4
213.2
156.7
Provision for income taxes
88.2
71.1
262.5
240.0
Depreciation expense
27.5
23.5
105.0
87.9
Amortization expense
95.2
93.2
373.0
367.5
Impairment of intangible assets
13.9
—
13.9
—
Restructuring and related business
transformation costs
8.0
10.5
32.3
22.9
Acquisition and other transaction related
expenses and non-cash charges
0.3
17.3
59.8
63.9
Stock-based compensation
15.2
16.7
58.8
51.9
Foreign currency transaction losses
(gains), net
(6.0
)
4.1
3.2
5.1
Loss on equity method investments
5.0
4.8
24.0
6.0
Loss on extinguishment of debt
—
—
3.0
13.5
Adjustments to LIFO inventories
(0.5
)
(2.0
)
6.7
12.0
Cybersecurity incident costs
—
—
0.5
2.3
Loss on asbestos sale
—
—
58.8
—
Interest income on cash and cash
equivalents
(7.6
)
(10.1
)
(43.3
)
(28.8
)
Other adjustments
(0.6
)
2.5
0.4
0.8
Adjusted EBITDA
$
532.3
$
500.5
$
2,018.1
$
1,786.8
Minus:
Interest expense
61.8
37.4
213.2
156.7
Income tax provision, as adjusted
104.8
92.7
385.2
345.2
Depreciation expense
27.5
23.5
105.0
87.9
Amortization of non-acquisition related
intangible assets
2.2
2.4
8.7
10.0
Interest income on cash and cash
equivalents
(7.6
)
(10.1
)
(43.3
)
(28.8
)
Adjusted Net Income
$
343.6
$
354.6
$
1,349.3
$
1,215.8
Free Cash Flow:
Cash flows from operating activities
526.2
581.4
1,396.7
1,377.4
Minus:
Capital expenditures
35.3
29.6
149.1
105.4
Free Cash Flow
$
490.9
$
551.8
$
1,247.6
$
1,272.0
INGERSOLL RAND INC. AND
SUBSIDIARIES
RECONCILIATION OF SEGMENT
ADJUSTED EBITDA TO NET INCOME
(Unaudited; in millions)
For the Three Months Ended
December 31,
For the Twelve Months Ended
December 31,
2024
2023
2024
2023
Orders
Industrial Technologies and Services
$
1,422.2
$
1,377.4
$
5,706.6
$
5,618.9
Precision and Science Technologies
377.8
293.0
1,398.9
1,203.5
Total Orders
$
1,800.0
$
1,670.4
$
7,105.5
$
6,822.4
Revenue
Industrial Technologies and Services
$
1,511.0
$
1,508.8
$
5,818.1
$
5,632.8
Precision and Science Technologies
387.6
312.6
1,416.9
1,243.3
Total Revenue
$
1,898.6
$
1,821.4
$
7,235.0
$
6,876.1
Segment Adjusted EBITDA
Industrial Technologies and Services
$
457.6
$
453.3
$
1,754.8
$
1,587.3
Precision and Science Technologies
106.8
94.1
418.8
372.8
Total Segment Adjusted EBITDA
$
564.4
$
547.4
$
2,173.6
$
1,960.1
Less items to reconcile Segment Adjusted
EBITDA to Income Before Income Taxes:
Corporate expenses not allocated to
segments
$
32.1
$
46.9
$
155.5
$
173.3
Interest expense
61.8
37.4
213.2
156.7
Depreciation and amortization expense
122.7
116.7
478.0
455.4
Impairment of intangible assets
13.9
—
13.9
—
Restructuring and related business
transformation costs
8.0
10.5
32.3
22.9
Acquisition and other transaction related
expenses and non-cash charges
0.3
17.3
59.8
63.9
Stock-based compensation
15.2
16.7
58.8
51.9
Foreign currency transaction losses
(gains), net
(6.0
)
4.1
3.2
5.1
Loss on extinguishment of debt
—
—
3.0
13.5
Adjustments to LIFO inventories
(0.5
)
(2.0
)
6.7
12.0
Cybersecurity incident costs
—
—
0.5
2.3
Loss on asbestos sale
—
—
58.8
—
Interest income on cash and cash
equivalents
(7.6
)
(10.1
)
(43.3
)
(28.8
)
Other adjustments
(0.6
)
2.5
0.4
0.8
Income Before Income Taxes
325.1
307.4
1,132.8
1,031.1
Provision for income taxes
88.2
71.1
262.5
240.0
Loss on equity method investments
(5.0
)
(4.8
)
(24.0
)
(6.0
)
Net Income
$
231.9
$
231.5
$
846.3
$
785.1
INGERSOLL RAND INC. AND
SUBSIDIARIES
ORDERS AND REVENUE
GROWTH/(DECLINE) BY SEGMENT(1)
(Unaudited)
Three Month Period Ended
December 31, 2024
Orders
Revenue
Ingersoll Rand
Organic decline
(0.3
%)
(2.8
%)
Impact of foreign currency
(0.7
%)
(0.8
%)
Impact of acquisitions
8.8
%
7.8
%
Total adjusted orders and revenue
growth
7.8
%
4.2
%
Industrial Technologies &
Services
Organic decline
(0.2
%)
(2.4
%)
Impact of foreign currency
(0.8
%)
(0.9
%)
Impact of acquisitions
4.3
%
3.4
%
Total adjusted orders and revenue
growth
3.3
%
0.1
%
Precision & Science
Technologies
Organic decline
(0.5
%)
(5.0
%)
Impact of foreign currency
(0.5
%)
(0.3
%)
Impact of acquisitions
29.9
%
29.3
%
Total adjusted orders and revenue
growth
28.9
%
24.0
%
1 Organic revenue growth/(decline), impact
of foreign currency, and impact of acquisitions are non-GAAP
measures. References to “impact of acquisitions” refer to GAAP
sales from acquired businesses recorded prior to the first
anniversary of the acquisition. The portion of GAAP revenue
attributable to currency translation is calculated as the
difference between (a) the period-to-period change in revenue
(excluding acquisition sales) and (b) the period-to-period change
in revenue (excluding acquisition sales) after applying prior year
foreign exchange rates to the current year period.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250213454379/en/
Investor Relations: Matthew Fort
Matthew.Fort@irco.com
Media: Sara Hassell Sara.Hassell@irco.com
Ingersoll Rand (NYSE:IR)
Historical Stock Chart
From Jan 2025 to Feb 2025
Ingersoll Rand (NYSE:IR)
Historical Stock Chart
From Feb 2024 to Feb 2025